Wellness Communications (366A) FY2026 Q3 Earnings Report

Quick View

Executive Summary

FY2026 Q3 results: Revenue 121.8B yen (YoY +4.8%), Operating Income 10.1B yen (+10.3%), Ordinary Income 9.9B yen (+8.3%), and Net Income 6.8B yen (+7.7%). The company delivered revenue growth combined with margin expansion, as operating margin improved to 8.3% from 7.9% in the prior year period. Despite modest top-line growth in the mid-single digits, operating leverage drove double-digit operating profit growth, reflecting improved cost management. Net income growth of 7.7% lagged operating income growth due to a marginal decline in non-operating profit contribution, though the gap between ordinary and net income remained within normal range. The company maintains a solid financial position with equity ratio of 62.3% and ROE of 12.0%, both exceeding industry median levels.

Performance Drivers

Revenue increased 5.5B yen or 4.8% YoY to 121.8B yen, driven primarily by the Medical Checkup Solution segment which accounts for 91.0% of total revenue. The Health Management Cloud segment revenue reached 9.4B yen, while Medical Institution Support contributed 1.7B yen. Gross profit margin of 19.0% remained below the 20% threshold, reflecting the company's low-margin business model concentrated in medical checkup solutions where pricing is constrained. Cost of sales increased 4.2% to 98.7B yen, slightly below revenue growth, enabling gross profit to expand 6.6% to 23.1B yen. SG&A expenses rose 7.4% to 13.0B yen, representing 10.6% of revenue, up from 10.4% in the prior period, suggesting incremental investment in selling and administrative functions. The combination of revenue growth and controlled cost increases drove operating income up 10.3% to 10.1B yen, with operating margin improving 0.4pt to 8.3%. Non-operating items resulted in a net expense of 0.2B yen, primarily from other non-operating expenses, causing ordinary income to increase 8.3% to 9.9B yen. Income tax expense of 3.1B yen yielded an effective tax rate of 31.3%, within the normal range. No material extraordinary items or impairments were disclosed. The performance pattern is revenue up, profit up, with operating leverage driving margin expansion despite modest top-line growth.

Segment Analysis

Health Management Cloud segment generated revenue of 9.4B yen with operating income of 5.1B yen, delivering an exceptional operating margin of 54.2%. This high-margin, cloud-based software business demonstrates strong profitability characteristics. Medical Checkup Solution segment, the company's core business accounting for 91.0% of total revenue, recorded 110.8B yen in sales with operating income of 4.8B yen and a margin of 4.4%. This segment's low margin reflects the service-intensive nature of medical checkup operations where material and labor costs are significant. Medical Institution Support segment contributed 1.7B yen in revenue with operating income of 0.2B yen at a 13.8% margin. The stark margin differential between segments highlights the strategic importance of scaling the Health Management Cloud business, which generates margins more than 12 times higher than the core Medical Checkup Solution segment. Cross-segment performance indicates the company is successfully developing higher-margin digital offerings while maintaining its established medical checkup service base.

Key Metrics

[Profitability] ROE 12.0% exceeds the industry median of 8.3%, driven by a net profit margin of 5.6%, total asset turnover of 1.333, and financial leverage of 1.61. Operating margin of 8.3% aligns with the industry median of 8.2%, demonstrating competitive operational efficiency. Gross profit margin of 19.0% remains below the 20% benchmark, reflecting the company's service-based business model with inherent margin constraints. [Cash Quality] Cash and deposits of 52.3B yen provide robust liquidity, covering short-term debt and operational needs with a short-term debt coverage ratio well above 1.0. [Investment Efficiency] Asset turnover of 1.333 significantly exceeds the industry median of 0.67, indicating superior efficiency in generating revenue from assets. Days sales outstanding of 69 days exceeds the industry median of 61 days, reflecting slower receivables collection that warrants attention. [Financial Health] Equity ratio of 62.3% exceeds the industry median of 59.2%, indicating a conservative capital structure. Current ratio of 231.9% significantly surpasses the industry median of 2.15x, demonstrating strong short-term liquidity. Debt-to-equity ratio of 0.61 reflects minimal leverage and ample borrowing capacity for future growth initiatives.

Cash Flow Analysis

Cash and deposits increased 24.4B yen YoY to 52.3B yen, representing an 87.7% increase that substantially strengthened the company's liquidity position. This significant cash accumulation reflects operating profit growth of 10.3% contributing to cash generation. Trade receivables increased 13.2B yen or 133.1% to 23.2B yen, outpacing revenue growth and indicating extended collection cycles with days sales outstanding reaching 69 days. Trade payables rose 17.3B yen or 174.3% to 27.2B yen, suggesting the company is effectively utilizing supplier credit to finance working capital needs. Inventories increased 1.5B yen or 283.9% to 2.1B yen, though remaining modest as a percentage of total assets given the service-oriented business model. The combination of cash accumulation and working capital expansion suggests operational cash generation is funding both liquidity building and business growth. Total assets increased 39.6B yen to 91.4B yen, with current assets rising 40.4B yen to 78.6B yen, while shareholders' equity grew 22.3B yen to 56.9B yen. Cash coverage of short-term liabilities stands at 1.54 times, indicating ample liquidity to meet obligations. The substantial year-over-year balance sheet growth warrants monitoring to ensure working capital efficiency is maintained as operations scale.

Earnings Quality

Ordinary income of 9.9B yen versus operating income of 10.1B yen shows a non-operating net expense of approximately 0.2B yen, representing 0.2% of revenue, a minimal impact indicating core operations drive substantially all profitability. Non-operating expenses consist primarily of miscellaneous items without material interest expense, reflecting the company's net cash position and minimal financial leverage. The marginal decline of 0.03B yen in non-operating income from the prior period has limited impact on overall profitability. Profit before tax of 9.9B yen converted to net income of 6.8B yen after income tax expense of 3.1B yen, yielding a tax burden coefficient of 0.687 and effective tax rate of 31.3%, both within normal ranges without indication of unusual tax factors. Operating income to revenue ratio of 8.3% improved from 7.9% YoY, demonstrating genuine operational improvement rather than non-recurring gains. The absence of disclosed extraordinary items or restructuring charges supports sustainable earnings quality. However, the significant increase in trade receivables growing faster than revenue, combined with days sales outstanding of 69 days, raises questions about the timing of cash realization from reported profits. While cash and deposits increased substantially, the lack of disclosed cash flow statement data prevents direct verification that operating cash flow exceeded net income, which would confirm high-quality, cash-backed earnings.

Guidance Update

Progress against full-year guidance shows revenue at 121.8B yen representing 82.4% of the 147.9B yen forecast, operating income at 10.1B yen achieving 81.5% of the 12.4B yen target, and net income at 6.8B yen reaching 79.1% of the 8.6B yen projection. With Q3 representing the nine-month point or 75% of the fiscal year, all metrics exceed standard progress rates, indicating performance tracking ahead of the seasonal norm. Revenue progress of 82.4% versus the 75% benchmark suggests a 7.4pt positive variance, while operating income progress of 81.5% reflects a 6.5pt favorable variance. Net income progress of 79.1% shows a 4.1pt positive variance, with all metrics demonstrating above-plan execution. The company revised its dividend forecast upward during the quarter, as noted in the dividend announcement dated February 13, 2026, reflecting confidence in full-year performance and commitment to enhanced shareholder returns. Forecast assumptions include continued growth in the Medical Checkup Solution segment and scaling of the high-margin Health Management Cloud business. The above-plan progress rates suggest the company is well-positioned to meet or potentially exceed full-year guidance, barring unforeseen developments in Q4. The revised dividend forecast indicates management confidence in both earnings visibility and cash generation to support increased distributions.

Shareholder Returns

The company declared a year-end dividend of 42.75 yen per share. The full-year dividend forecast stands at 34.40 yen per share, reflecting the impact of a 2-for-1 stock split effective February 1, 2026. Adjusting for the stock split, the forecasted dividend represents an increase from the prior year, as detailed in the shareholder return policy revision announcement dated February 13, 2026. Based on net income of 6.8B yen and average shares outstanding of 11,937 thousand, basic EPS of 114.40 yen translates to a calculated payout ratio of 78.1% using the pre-split year-end dividend of 42.75 yen and the Q3 annualized earnings. This elevated payout ratio, approaching 80%, indicates an aggressive distribution policy that leaves limited earnings retention for internal reinvestment or buffer against performance variability. No share buyback activity was disclosed for the current period. The absence of buyback data means the total return ratio equals the dividend payout ratio of 78.1%. The revised upward dividend forecast demonstrates management's commitment to returning capital to shareholders, though the sustainability of this payout level depends on continued earnings growth and cash flow generation. With substantial cash reserves of 52.3B yen and minimal debt, near-term dividend coverage appears secure, though the high payout ratio limits financial flexibility for acquisitions or unexpected operational needs.

Risk Factors

Margin pressure from low gross profit margin of 19.0%, below the 20% benchmark, constrains profitability improvement and leaves limited buffer to absorb cost increases or pricing pressure in the core Medical Checkup Solution segment which generates 91% of revenue at just 4.4% operating margin. Working capital deterioration evidenced by trade receivables increasing 133.1% YoY far exceeding the 4.8% revenue growth, with days sales outstanding extended to 69 days versus 61-day industry median, creating potential cash flow pressure and elevated bad debt risk if collection discipline is not restored. Dividend sustainability concerns arising from 78.1% payout ratio leaving minimal retained earnings for reinvestment, with full-year dividend forecast of 34.40 yen per share requiring 8.6B yen net income to maintain current distribution level, making the dividend vulnerable to any earnings shortfall despite current strong cash position of 52.3B yen.

Industry Benchmark (Reference - Proprietary Data)

[Industry Position] (Reference - Proprietary Analysis)

Profitability: ROE 12.0% exceeds industry median of 8.3%, ranking in the upper quartile and demonstrating superior capital efficiency driven by above-median asset turnover of 1.333 versus industry median of 0.67. Operating margin of 8.3% aligns with industry median of 8.2%, while net profit margin of 5.6% falls below the industry median of 6.0%, suggesting slightly higher tax burden or non-operating expenses relative to peers.

Financial Health: Equity ratio of 62.3% exceeds industry median of 59.2%, reflecting a conservative capital structure with room for strategic leverage if needed. Current ratio of 231.9% significantly surpasses industry median of 2.15x, indicating superior liquidity though potentially excess cash that could be deployed more productively.

Efficiency: Asset turnover of 1.333 substantially exceeds industry median of 0.67, ranking the company among the most efficient revenue generators in the IT and Telecom sector. However, receivables turnover of 69 days exceeds the industry median of 61 days, indicating slower collection than peers and representing a relative efficiency weakness.

Growth: Revenue growth of 4.8% YoY trails the industry median of 10.4%, placing the company in the lower half of sector growth rates and suggesting market share challenges or mature market conditions in core medical checkup services.

(Industry: IT and Telecom (n=104 companies), Period: 2025-Q3, Source: Proprietary analysis)

Key Takeaways from Earnings

Operating leverage driving margin expansion: The company demonstrated ability to convert modest 4.8% revenue growth into 10.3% operating income growth, with operating margin improving 0.4pt to 8.3%, indicating effective cost management and scale benefits that should continue as revenue grows, particularly as the high-margin Health Management Cloud segment scales from its current 7.7% revenue contribution.

Strategic positioning in digital health transformation: The stark margin differential between the Health Management Cloud segment at 54.2% operating margin versus the legacy Medical Checkup Solution at 4.4% margin highlights the transformation opportunity, with the digital cloud business demonstrating software economics that could materially improve consolidated profitability as this segment grows and cross-selling to the established medical checkup customer base progresses.

Working capital management requiring attention: Trade receivables growth of 133.1% vastly exceeding revenue growth of 4.8%, combined with days sales outstanding of 69 days versus industry median of 61 days, signals deteriorating collection efficiency that, if not addressed, could pressure cash conversion despite strong reported earnings, while the simultaneous 174.3% increase in trade payables suggests reliance on extended supplier credit to fund working capital expansion.

---

This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.

---

AI Financial Analysis

Executive Summary

FY2026 Q3 performance was solid, with revenue growth translating into faster operating-profit growth and an above-plan cumulative pace versus full-year guidance. Revenue rose 4.8% year on year to ¥12.183bn. Operating income increased 10.3% to ¥1.013bn, outpacing sales growth by 5.5 percentage points. Ordinary income rose 8.3% to ¥0.993bn, while net income increased 7.7% to ¥0.682bn. The operating margin improved 42bp year on year to 8.3% from 7.9%. Gross margin rose modestly by 16bp to 19.0%, indicating limited but positive improvement in gross profitability. The SG&A-to-sales ratio declined by 26bp to 10.6%, demonstrating favorable operating leverage. The 19.0% gross margin remains below the 20% quality-alert threshold and leaves the company relatively exposed to changes in procurement costs, service-delivery costs, or pricing. Annualized ROE was 16.0%, exceeding the 15% benchmark for excellent profitability. The DuPont outcome was supported by a 5.6% net margin, annualized asset turnover of 1.777x, and financial leverage of 1.61x. The balance sheet strengthened substantially, with cash and deposits increasing 87.7% year on year to ¥5.230bn and equity rising to ¥5.693bn. Liquidity is ample, as shown by a 231.9% current ratio and 225.7% quick ratio. Q3 cumulative revenue represents 82.4% of the ¥14.790bn full-year forecast, 7.4 percentage points above the standard 75% Q3 pace. Operating income is at 81.8% of the annual plan and net income is at 79.8%, also ahead of normal seasonality. Achieving guidance requires Q4 revenue of ¥2.607bn, operating income of ¥0.226bn, and net income of ¥0.173bn, implying a materially lower Q4 operating margin of approximately 8.7%? No, the implied Q4 operating margin is 8.7%, broadly in line with the Q3 cumulative margin. The principal forward implication is that the company has a reasonable buffer to deliver its forecast, while investors should monitor whether gross-margin improvement can persist as receivables, inventories, and trade payables have expanded sharply alongside business scale.

Profitability Analysis

Annualized ROE of 16.0% decomposes into a 5.6% net profit margin, annualized asset turnover of 1.777x, and financial leverage of 1.61x. The most evident year-on-year improvement in the income statement is operating profitability: operating income grew 10.3%, faster than 4.8% revenue growth. Operating margin expanded 42bp to 8.3%, placing the company within the stated 8-15% good operating-margin range. Gross margin improved 16bp to 19.0%, from approximately 18.8% in the prior-year period. SG&A increased only 2.3% to ¥1.297bn, well below revenue growth, reducing the SG&A ratio to 10.6% from 10.9%. This operating leverage was the main source of the margin expansion rather than a large gross-margin step-up. Net margin increased slightly to 5.6% from approximately 5.5%, which is within the 5-10% good range. The tax burden was 0.687, equivalent to a 31.3% effective tax rate, and modestly restrained conversion of pre-tax profit into net income. The interest burden was 0.980, showing that non-operating costs reduced EBIT only marginally. Intangible assets were ¥0.792bn, or 8.7% of assets, including ¥0.631bn of software; this is a balanced level rather than an asset-base concentration. The sustainability of margin gains depends primarily on maintaining SG&A discipline and protecting the sub-20% gross margin, rather than on financial leverage.

Growth Assessment

Revenue growth of 4.8% to ¥12.183bn was moderate but accompanied by stronger 10.3% operating-income growth, indicating improved earnings conversion. The full-year forecast calls for 5.2% revenue growth, 11.7% operating-income growth, and 10.2% net-income growth. Q3 cumulative performance is modestly ahead of this annual objective, with revenue at 82.4% of guidance, operating income at 81.8%, ordinary income at 81.9%, and net income at 79.8%. The required Q4 revenue of ¥2.607bn represents 17.6% of full-year guidance, below the standard 25% quarterly contribution. Required Q4 operating income is ¥0.226bn, or 18.2% of the full-year target. The implied Q4 operating margin of 8.7% is slightly above the Q3 cumulative 8.3% margin, so forecast delivery still requires continued cost control rather than a sharp earnings slowdown. Gross profit grew 5.7% to ¥2.310bn, modestly faster than revenue, consistent with the 16bp gross-margin improvement. Revenue sustainability should be assessed against the expansion in trade receivables and contract liabilities, which may reflect a larger operating base and customer billing activity. The absence of segment-level disclosure means performance concentration cannot be assessed by business line.

Financial Health

Financial health is strong on reported liquidity and equity capitalization. Current assets were ¥7.860bn against current liabilities of ¥3.390bn, producing a current ratio of 231.9%, well above the 1.0x warning threshold. The quick ratio was also high at 225.7%, indicating that liquidity does not depend on inventory realization. Working capital was ¥4.470bn. Cash and deposits totaled ¥5.230bn, equal to 57.2% of total assets and up ¥2.443bn, or 87.7%, year on year. Total equity increased ¥2.236bn to ¥5.693bn, while the equity ratio was 62.2%. The reported debt-to-equity ratio of 0.61x is conservative and well below the 2.0x aggressive-capital-structure threshold. Noncurrent liabilities were only ¥0.059bn, while liabilities were predominantly current at ¥3.390bn. This maturity profile is mitigated by cash exceeding current liabilities by ¥1.840bn and by the strong quick ratio. Trade payables rose ¥1.727bn, or 174.3%, to ¥2.718bn, accounting for the bulk of current liabilities. Trade receivables increased ¥1.323bn, or 133.1%, to ¥2.316bn, while inventories increased ¥0.154bn, or 283.9%, to ¥0.208bn. The parallel expansion of receivables and payables is consistent with higher transaction volumes and settlement timing, but it increases the importance of collection discipline and supplier-payment management. Contract liabilities more than doubled to ¥0.280bn from ¥0.129bn, providing an additional indication of increased billed or prepaid customer activity. Capital stock and capital surplus together increased by approximately ¥2.236bn, closely matching the increase in total equity and strengthening the funding base. Asset retirement obligations were ¥0.044bn, representing a limited long-term balance-sheet obligation.

Notable B/S Changes

Cash and deposits: +¥2.443bn (+87.7%) to ¥5.230bn — substantially improved liquidity; the increase coincided with a roughly ¥2.236bn rise in equity capital. Accounts receivable: +¥1.323bn (+133.1%) to ¥2.316bn — indicates a substantially larger receivables base relative to 4.8% revenue growth; collection performance is an important monitoring item. Accounts payable: +¥1.727bn (+174.3%) to ¥2.718bn — the largest liability movement and a major source of short-term operating funding; monitor settlement terms and payment timing. Inventories: +¥0.154bn (+283.9%) to ¥0.208bn — small at 2.3% of total assets but growing rapidly; monitor turnover and demand alignment. Capital stock and capital surplus: combined increase of approximately ¥2.236bn to ¥2.576bn — materially strengthened the equity base and underpinned the increase in cash and deposits. Contract liabilities: +¥0.151bn (+116.8%) to ¥0.280bn — increased prepaid or billed customer balances, supportive of operating funding and indicative of expanded customer activity.

Cash Flow Quality

The income statement shows a positive profitability profile, with net income of ¥0.682bn and operating income of ¥1.013bn for the nine-month cumulative period. Working-capital movements are material: trade receivables increased by ¥1.323bn year on year, inventories by ¥0.154bn, and trade payables by ¥1.727bn. The increase in payables exceeded the combined increase in receivables and inventories by approximately ¥0.250bn, which is supportive of operating cash conversion on a balance-sheet movement basis. However, the sizable increases in both receivables and payables mean cash conversion remains sensitive to payment terms, customer collections, and the timing of supplier settlements. Contract liabilities increased by ¥0.151bn, which is also supportive of near-term operating funding. Cash and deposits increased by ¥2.443bn to ¥5.230bn, alongside a ¥2.236bn increase in equity, indicating that the cash build was substantially supported by capital strengthening in addition to retained profits. Software represented ¥0.631bn, or 79.7% of intangible assets, so ongoing software investment and related capitalization policies remain relevant to assessing cash earnings conversion. The current liquidity position provides substantial capacity to absorb ordinary working-capital volatility.

Dividend Sustainability

The full-year dividend forecast is ¥34.4 per share, following a revision to the shareholder-return policy and dividend forecast. Based on forecast EPS of ¥70.87, the implied dividend payout ratio is approximately 48.5%. This is below the 60% sustainability benchmark and indicates a balanced allocation between shareholder distributions and earnings retention. The forecast dividend is supported by the company’s ¥5.230bn cash balance, ¥5.693bn equity base, and strong liquidity ratios. Retained earnings were ¥3.112bn, up 16.9% year on year. The Q2 dividend was ¥0 per share, indicating that the planned annual distribution is weighted toward the year-end payment. The February 2026 two-for-one stock split should be considered when comparing per-share figures across periods. Continued dividend capacity will depend on preserving operating margins and maintaining disciplined working-capital management as the business scales.

Risk Assessment

Business risks include Gross-margin risk: the 19.0% gross margin is below the 20% quality-alert threshold. A relatively thin gross-profit buffer makes profitability sensitive to service-delivery costs, procurement conditions, and customer pricing., Working-capital execution risk: trade receivables increased 133.1% to ¥2.316bn and inventories increased 283.9% to ¥0.208bn. Delayed collections or slower inventory turnover could reduce liquidity conversion despite the currently strong cash position., IT-services risk: software assets total ¥0.631bn. Technology obsolescence, cybersecurity incidents, data-privacy requirements, and the need to retain specialized personnel could raise costs or require additional investment., Forecast execution risk: full-year delivery requires an 8.7% Q4 operating margin, slightly above the 8.3% cumulative margin, requiring continued SG&A efficiency and gross-margin stability..

Financial risks include Settlement-timing risk: trade payables increased 174.3% to ¥2.718bn and represent a large portion of current liabilities. A reduction in supplier credit terms could temporarily increase funding needs., Tax-rate sensitivity: the 31.3% effective tax rate and 0.687 tax burden reduce conversion from pre-tax income to net income., Intangible-asset execution risk: intangible assets are ¥0.792bn, including ¥0.631bn of software. Although only 8.7% of assets, unsuccessful software deployment or reduced economic usefulness could pressure future earnings..

Key concerns include The LOW_GROSS_MARGIN alert requires attention: 19.0% is only marginally below the 20% threshold. The root cause is that cost of sales consumes approximately 81% of revenue; while the margin improved 16bp year on year, sustained profitability improvement depends on preventing cost escalation. The impact is a narrower cushion against pricing pressure and cost inflation., The balance-sheet expansion should be monitored for quality: receivables, inventories, and payables have all risen much faster than revenue. The pattern can reflect business growth and normal billing cycles, but its investment relevance is that collection performance and supplier financing now have a larger influence on liquidity., No single financial-stress signal is evident currently: the current ratio is 231.9%, the quick ratio is 225.7%, the D/E ratio is 0.61x, and cash exceeds current liabilities..

Investment Implications

Key takeaways include Revenue grew 4.8%, but operating income grew 10.3%, producing a 42bp operating-margin expansion to 8.3%., Annualized ROE of 16.0% is strong and is supported by a 5.6% net margin, 1.777x annualized asset turnover, and 1.61x financial leverage., Q3 cumulative results are ahead of the normal 75% progress benchmark for revenue, operating income, ordinary income, and net income., Liquidity is strong, with ¥5.230bn of cash, a 231.9% current ratio, and a 225.7% quick ratio., The projected ¥34.4 DPS implies an approximately 48.5% dividend payout ratio based on forecast EPS, within a sustainable range..

Metrics to watch include Gross margin, particularly whether it can remain above or improve from 19.0%, SG&A-to-sales ratio and the durability of operating leverage, Trade receivables growth and collection performance, Trade payables growth and supplier settlement terms, Q4 operating-margin delivery versus the approximately 8.7% implied by full-year guidance, Software asset growth and the productivity of related investment.

Regarding relative positioning, On the disclosed metrics, the company combines good operating profitability, excellent annualized ROE, conservative reported leverage, and very strong liquidity. Its relative constraint is a gross margin just below the stated 20% alert level, making execution on cost control and working-capital discipline more important than balance-sheet funding capacity.